Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed
| Country | United States |
|---|---|
| Deadline | Not published |
| Published | 2023-11-24 |
| Sectors | Health & life sciences, SME & startup support |
| Source | Grants.gov (US) |
Summary
Funding opportunity FOR-FD-24-007. CFDA: 93.103
The buyer, the value, the full description and the link to the official notice are available with a free account.